DSS, Inc. (DSS)
NYSEAMERICAN: DSS · Real-Time Price · USD
1.038
+0.038 (3.82%)
Dec 5, 2025, 4:00 PM EST - Market closed
DSS, Inc. Revenue
DSS, Inc. had revenue of $6.39M in the quarter ending September 30, 2025, with 14.96% growth. This brings the company's revenue in the last twelve months to $21.95M, up 7.30% year-over-year. In the year 2024, DSS, Inc. had annual revenue of $18.87M, down -26.14%.
Revenue (ttm)
$21.95M
Revenue Growth
+7.30%
P/S Ratio
0.40
Revenue / Employee
$220,460
Employees
100
Market Cap
9.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.87M | -6.68M | -26.14% |
| Dec 31, 2023 | 25.55M | -2.21M | -7.95% |
| Dec 31, 2022 | 27.75M | 7.73M | 38.59% |
| Dec 31, 2021 | 20.03M | 4.66M | 30.32% |
| Dec 31, 2020 | 15.37M | -184.00K | -1.18% |
| Dec 31, 2019 | 15.55M | -2.97M | -16.01% |
| Dec 31, 2018 | 18.52M | -146.79K | -0.79% |
| Dec 31, 2017 | 18.66M | -515.73K | -2.69% |
| Dec 31, 2016 | 19.18M | 1.67M | 9.55% |
| Dec 31, 2015 | 17.51M | -782.39K | -4.28% |
| Dec 31, 2014 | 18.29M | 835.05K | 4.78% |
| Dec 31, 2013 | 17.45M | 337.17K | 1.97% |
| Dec 31, 2012 | 17.12M | 3.73M | 27.88% |
| Dec 31, 2011 | 13.38M | 2.02K | 0.02% |
| Dec 31, 2010 | 13.38M | 3.47M | 35.01% |
| Dec 31, 2009 | 9.91M | 3.27M | 49.20% |
| Dec 31, 2008 | 6.64M | 651.81K | 10.88% |
| Dec 31, 2007 | 5.99M | 1.68M | 39.06% |
| Dec 31, 2006 | 4.31M | 3.04M | 240.21% |
| Dec 31, 2005 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amazon.com | 691.33B |
| Toyota Motor | 333.71B |
| The Home Depot | 166.19B |
| Alibaba Group Holding | 142.16B |
| Tesla | 95.63B |
| Lowe's Companies | 84.26B |
| The TJX Companies | 58.98B |
| PDD Holdings | 58.79B |
DSS News
- 7 months ago - DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth - GlobeNewsWire
- 10 months ago - DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth - GlobeNewsWire
- 10 months ago - DSS, Inc. Issues Letter to Shareholders - GlobeNewsWire
- 11 months ago - LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals - Business Wire
- 1 year ago - DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value - GlobeNewsWire
- 1 year ago - AmericaFirst Funds Trust Announces Changes to Board of Trustees - GlobeNewsWire
- 1 year ago - DSS, Inc. Names Jason Grady as Interim Chief Executive Officer - GlobeNewsWire
- 2 years ago - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." - GlobeNewsWire